Financial Services

Global gaming giant Zitro sees huge success with its FANTASY cabinet, a high-tech marvel shaking up casino floors across the United States.

A landmark partnership brings AgriNext to North America, aiming to replace paperwork with a seamless digital experience for farmers and ranchers.

Launched in 2025, Mellow hit $110M in sales in nine months by mastering TikTok. Now it aims to own the $300B sleep market, but can the product live up to the hype?

How Samsung's first hotel outside Korea, Shilla Monogram Danang, is blending tech precision with Vietnamese heritage to win awards and dominate the market.

A French biopharma's leap in synthetic lipid production de-risks its lead drug, eyes a vast sepsis market, and creates new commercial avenues.

From a $20k loan to a major wellness player, a women-founded brand proves sustainability and science are the future of sleep and business.

Firan Technology Group sets its Q1 earnings date. With a record 2025 behind it, all eyes are on whether it can sustain growth amid industry trends.

Portland City Grill's five-year lease renewal at Big Pink is more than a business deal; it's a major vote of confidence in downtown's rocky recovery.

After a year of strategic shifts, Nortech Systems reports a strong Q4, signaling its restructuring efforts and nearshoring focus are finally paying off.

Thor Equities' acquisition of a fully-leased historic building at 1165 Broadway signals strong confidence in NoMad's booming mixed-use real estate market.

INNOVATE Corp. reports a 62% Q4 revenue surge, but a 'going concern' warning and looming debt have forced the company to explore selling key assets.

Crinetics Pharmaceuticals aims to disrupt Brazil's acromegaly treatment with Palsonify, a once-daily pill challenging the standard of monthly injections.

An Omaha couple's dedication to community and accessibility has earned them a top national award, highlighting a growing trend in home mobility solutions.

The pharma firm hit pause on a crucial reverse stock split needed to keep its Nasdaq listing, citing "timing considerations" and raising investor questions.

EnerSys will unveil its strategic framework and technology roadmap, outlining its plan to navigate the energy transition and capitalize on market growth.

With critical data due in 2026 and a leaner financial strategy, Zentalis is advancing its targeted therapy for a hard-to-treat ovarian cancer.

After a record 2025 and claiming the #1 shaft spot at Club Champion, Newton Golf preps to show investors how physics is reshaping the golf market.

Keurig Dr Pepper's upcoming Q1 results are more than just numbers; they're the first look at a company on the brink of a massive transformation.

A promising oral therapy for a rare, aggressive lung cancer is now under review in Europe, offering a new option for patients with limited treatments.

An inmate's escape by allegedly impersonating another has triggered a national investigation, exposing critical flaws in Canada's correctional system.